Sarcomatoid carcinoma after radiation treatment of prostatic adenocarcinoma

Lauwers, 1993, Carcinosarcoma of the prostate, Am J Surg Pathol, 17, 342, 10.1097/00000478-199304000-00004 Young, 1998, Tumors of the prostate gland, seminal vesicles, male urethra and penis, 238 Lopez-Beltran, 1998, Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases, J Urol, 159, 1497, 10.1097/00005392-199805000-00023 Kohn, 1984, Radiation carcinogenesis, N Engl J Med, 310, 504, 10.1056/NEJM198402233100807 Canfield, 2001, Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?, Tech Urol, 7, 294 Neugut, 1997, Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma, Cancer, 79, 1600, 10.1002/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0 Cahan, 1998, Sarcoma arising in irradiated bone: report of 11 cases, Cancer, 82, 8, 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W Shannon, 1992, Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients, Cancer, 69, 2676, 10.1002/1097-0142(19920601)69:11<2676::AID-CNCR2820691109>3.0.CO;2-P Dundore, 1995, Carcinosarcoma of the prostate. Report of 21 cases, Cancer, 76, 1035, 10.1002/1097-0142(19950915)76:6<1035::AID-CNCR2820760618>3.0.CO;2-8 Locke, 1986, Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostatic gland, Am J Clin Pathol, 85, 375, 10.1093/ajcp/85.3.375 Delahunt, 1999, Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression, Anticancer Res, 19, 4279 Smith, 2003, The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer, J Urol, 169, 1219, 10.1097/01.ju.0000056085.58221.80 Parsons, 2001, P63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis, Urology, 58, 619, 10.1016/S0090-4295(01)01311-5 Nylander, 2002, Differential expression of p63 isoforms in normal tissues and neoplastic cells, J Pathol, 198, 417, 10.1002/path.1231 Kaufmann, 2001, Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas, Am J Clin Pathol, 116, 823, 10.1309/21TW-2NDG-JRK4-PFJX